Notably, in another patient cohort (Hacettepe cohort) which has follow up data, we demonstrated that high TACC3 protein expression is significantly associated with worse overall survival in TNBC subtype (Fig. 1G, H), further supporting the role of TACC3 in highly aggressive breast tumors with CA. Here, TACC3 is linked to cancer.